Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF

Clinical trial NCT04739215 · UNKNOWN

Trial details

NCT number: NCT04739215
Sponsor: Hospital General Universitario Gregorio Marañon
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Heart Failure With Preserved Ejection Fraction

Start date: 2021-01-15
Primary completion: 2022-12-30
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.